drugset / Trial / NCT01859234
89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to see whether 89Zr-bevacizumab PET scanning is feasible in relapsing multiple myeloma patients.
Timeline
- Start
- 2013-05
- Primary completion
- 2014-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 89Zr-bevacizumab | Monoclonal antibody | 5 mg | Intravenous |